Searched for
ASTRAZENECA FINANCIAL GUIDANCE 2025
Investors to continue to monitor Kaynes Technology for governance improvement: InGovernThe electronic manufacturing services company has struggled with a slew of guidance revisions, higher working capital intensity, cash flow ...- Scanning cancer, up close & personal: A revolution is underway in cancer diagnosisA gene-based test called next-generation sequencing can identify precise mutations, which can then be treated with targeted therapies. Sinc...
- US Stock Market: Warsh reshapes Fed playbook with leaner messaging and reform agendaUS Federal Reserve Chair Kevin Warsh signalled a major shift in central bank communication by adopting shorter policy statements and focusi...
- Power sector stocks regain momentum on rising electricity demand and strong investment cycleRising electricity demand and a strong investment cycle lift outlook for power companies.
- Quote of the day by Barack Obama: “What makes you a man is not the ability to make a child, it's the courage to raise one”—a powerful lesson on true fatherhood, responsibility and strengthQuote of the Day: A powerful quote attributed to former US President Barack Obama redefines fatherhood, emphasizing the courage to raise a ...
- Cancer, Leo, Virgo Horoscope Today for June 21, 2026: Major Financial Gains and Life-Changing Cosmic GuidanceYour Daily Horoscope Today emphasizes financial security, radiant self-expression, and quiet emotional healing. It is a powerful day to bal...
- Warsh's gamble: A quieter Federal Reserve could mean volatile markets, higher ratesNew Federal Reserve Chair Kevin Warsh is significantly reducing the central bank's communication, particularly "forward guidance" on intere...
- Capricorn, Aquarius, Pisces Horoscope Today for June 20, 2026: Relationship Breakthroughs, Financial Insights & Wellness GuidanceYour Daily Horoscope Today emphasizes emotional honesty, strengthening relationships, and streamlining daily routines. It is a powerful day...
- MTAR Technologies shares surge 5%, deliver multibagger returns of 138% in just 3 monthsMTAR Technologies shares surged to a fresh 52-week high, extending a remarkable 138% rally in three months. Strong international order wins...
- Hotel chains unfazed despite geopolitical shocks, high fuel costsHotel chains in India are reporting double-digit revenue growth in the April–June quarter despite geopolitical tensions, higher fuel costs ...
- Should long term investors bet on Turtlemint Fintech IPO?Insurance platform Turtlemint Fintech Solutions aims to raise ₹882 crore via IPO to boost technology and working capital. Despite revenue g...
- Investors brace for less predictable Fed as Warsh rewrites playbookKevin Warsh's first Federal Reserve meeting as chair saw interest rates held steady, but a shift away from forward guidance blindsided trad...
- JLR projects revenue growth and return to profit in FY27, doubles down on USJaguar Land Rover anticipates a strong comeback in financial year 2027. The company projects a 13% revenue increase and a return to profita...
- What should international students know about Germany's blocked account requirement?Germany requires international students and job seekers to open a blocked account, known as a Sperrkonto, to prove financial self-sufficien...
- Global drugmakers rush to boost US presence as tariff threat loomsGlobal drug companies are boosting U.S. production and stockpiling medicines. This is a response to potential tariffs on branded drugs. Com...
- Statistical system may get AI overhaul, data to be treated as asset: MoSPI SecyIndia is set to modernize its statistical system. Artificial intelligence will be integrated into official data. A national business regist...
- China's May loan growth dips on weak demandAggregate financing, a broad measure of credit, increased ¥2.03 trillion ($300 billion), according to Bloomberg calculations based on data ...
- AstraZeneca's Enhertu gets regulatory approval in India for first-line HER2-positive breast cancerAstraZeneca Pharma India has secured approval from India's drug regulator for its smart chemotherapy drug Enhertu. This allows for its impo...
- India a major growth market for Celonis, says senior execThe Germany-based company said it already serves 260 global capability centres (GCCs) in India, counting companies such as Mercedes-Benz, H...
- Novartis experimental actinium-based drug shows promise in prostate cancer treatment: StudyNovartis' new experimental actinium-based drug shows promise against prostate cancer. Early data on Sunday revealed anti-tumour activity, e...
Load More
